Dergiler / Adıyaman Üniversitesi Sağlık Bilimleri Dergisi / 2026 / Cilt: 12 Sayı: 2

İyonize radyasyonun monoklonal antikorlar ile etkileşim parametrelerinin analizi: Teorik çalışma

Analysis of interaction parameters between ionizing radiation and monoclonal antibodies: A theoretical study

Halime Erzen Yıldız(VAN YÜZÜNCÜ YIL ÜNİVERSİTESİ, VAN SAĞLIK HİZMETLERİ MESLEK YÜKSEKOKULU)0000-0002-0603-1815
Berna Oto(VAN YÜZÜNCÜ YIL ÜNİVERSİTESİ)0000-0003-4565-1790
Hamza Tunç(VAN YÜZÜNCÜ YIL ÜNİVERSİTESİ)0000-0002-2787-8126
Sayfa
138–149
Yayın Tarihi
2026-08-20
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Bulgular: μ/ρ, Zeff ve Nel değerleri Compton saçılmasının baskın olduğu enerji bölgesinde azalırken, EBF ve EABF en yüksek değerlerine ulaştı.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Amaç: EGFR hedefli monoklonal antikorların gama ışını zırhlama özelliklerini kütle zayıflatma katsayısı (μ/ρ), etkin atom numarası (Zeff), elektron yoğunluğu (Nel), maruziyet birikim faktörü (EBF) ve enerji soğurma birikim faktörü (EABF) açısından değerlendirmek.
📊
Temel Bulgular & Veri:Gereç ve Yöntem: Teorik μ/ρ değerleri WinXCom yazılımı ile hesaplandı.
💡
Sonuç & Katkı:Bulgular: μ/ρ, Zeff ve Nel değerleri Compton saçılmasının baskın olduğu enerji bölgesinde azalırken, EBF ve EABF en yüksek değerlerine ulaştı.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Monoklonal antikorlar · Radyasyon · Zayıflatma parametreleri

Özet

Amaç: EGFR hedefli monoklonal antikorların gama ışını zırhlama özelliklerini kütle zayıflatma katsayısı (μ/ρ), etkin atom numarası (Zeff), elektron yoğunluğu (Nel), maruziyet birikim faktörü (EBF) ve enerji soğurma birikim faktörü (EABF) açısından değerlendirmek. Gereç ve Yöntem: Teorik μ/ρ değerleri WinXCom yazılımı ile hesaplandı. Bu değerler kullanılarak farklı foton enerjileri ve ortalama serbest yol (mfp) değerleri için Zeff, Nel, EBF ve EABF belirlendi. Bulgular: μ/ρ, Zeff ve Nel değerleri Compton saçılmasının baskın olduğu enerji bölgesinde azalırken, EBF ve EABF en yüksek değerlerine ulaştı. Sonuç: Monoklonal antikorların gama ışını zırhlama özellikleri büyük ölçüde elementel bileşimleri, özellikle düşük atom numaralı elementlerin (C, H, N ve O) baskınlığı tarafından belirlenmektedir.

Abstract

Aim: To evaluate the gamma-ray shielding properties of EGFR-targeting monoclonal antibodies by determining the mass attenuation coefficient (μ/ρ), effective atomic number (Zeff), electron density (Nel), exposure buildup factor (EBF), and energy absorption buildup factor (EABF). Materials and Methods: Theoretical μ/ρ values were calculated using WinXCom software, and Zeff, Nel, EBF, and EABF were determined for different photon energies and mean free paths. Results: μ/ρ, Zeff, and Nel decreased in the Compton scattering region, while EBF and EABF reached their maximum values. Conclusion: The results indicate that the gamma-ray attenuation The gamma-ray shielding characteristics of monoclonal antibodies are primarily determined by their elemental composition, particularly the predominance of low atomic number elements (C, H, N, and O).

🔖

Bu Makaleye Atıf Yap

Yıldız, H. E., Oto, B., Tunç, H. (2026). İyonize radyasyonun monoklonal antikorlar ile etkileşim parametrelerinin analizi: Teorik çalışma. Adıyaman Üniversitesi Sağlık Bilimleri Dergisi, Cilt: 12 Sayı: 2, 138–149. https://doi.org/10.30569/adiyamansaglik.1870966

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (37)

  1. López-Morales CA, Miranda-Hernández MP, Juárez-Bayardo LC, et al. Physicochemical and biological characterization of a biosimilar trastuzumab. BioMed Research International. 2015; 1:427235.
  2. Vincenzi B, Schiavon G, Silletta M, et al. The biological properties of cetuximab. Critical Reviews in Oncology/Hematology. 2008;68(2):93–106.
  3. Borker A, Choudhary N. Rituximab. Indian Pediatrics. 2011;48(8):627–632.
  4. Goldberg R, Kirkpatrick P. Cetuximab. Nature Reviews Drug Discovery. 2005;4.
  5. Weiner GJ. Rituximab: mechanism of action. Seminars in Hematology. 2010;47(2):115–123.
  6. Flores-Ortiz LF, Campos-García VR, Perdomo-Abúndez FC, et al. Physicochemical properties of rituximab. Journal of Liquid Chromatography & Related Technologies. 2014;37(10):1438–1452.
  7. Marinko T, Dolenc J, Bilban-Jakopin C. Cardiotoxicity of concomitant radiotherapy and trastuzumab for early breast cancer. Radiology and Oncology. 2014;48(2):105.
  8. Boekhout AH, Beijnen JH, Schellens JH. Trastuzumab. The Oncologist. 2011;16(6):800–810.
  9. Garcia J, Hurwitz HI, Sandler AB, et al. Bevacizumab (Avastin®) in cancer treatment: a review of 15 years of clinical experience and future outlook. Cancer Treatment Reviews. 2020;86:102017.
  10. Kazazi-Hyseni F, Beijnen JH, Schellens JH. Bevacizumab. The Oncologist. 2010;15(8):819.
  11. Keating GM. Bevacizumab: a review of its use in advanced cancer. Drugs. 2014;74(16):1891–1925.
  12. Hiremath GB, Ayachit NH, Badiger NM. Investigation of shielding properties of gamma and neutrons in some natural radioprotective drugs. Radiation Effects and Defects in Solids. 2024;179(3–4):344–357.
  13. Tuğrul T. Investigation of mass attenuation coefficients, effective atomic numbers, and effective electron density for some molecules: study on chemotherapy drugs. Journal of Radiation Research and Applied Sciences. 2020;13(1):758–764.
  14. Mohammed SI, Taqi AH. Mass attenuation coefficient of electromagnetic radiation for human tissues. Journal of Radiation Research and Applied Sciences. 2025;18(1):101255.
  15. Büyükyıldız M, Kurudirek M. Radiological properties of healthy, carcinoma and equivalent breast tissues for photon and charged particle interactions. International Journal of Radiation Biology. 2018;94(1):70–78.
  16. Rafiei MM, Parsaei S, Kaur P, Singh KJ, Büyükyıldız M, Kurudirek M. Study of low-energy photon interactions below 1 keV for some biological molecules of human body. European Physical Journal Plus. 2022;137(2):262.
  17. Islam S, Mahmoud KA, Sayyed MI, Alim B,Rahman MM, Mollah AS. Study on the radiation attenuation properties of locally available bees-wax as a tissue equivalent bolus material in radiotherapy. Radiation Physics and Chemistry. 2020;172:108559.
  18. Büyükyıldız M, Kaur P, Thakur S, Atlı R. Study of phantom materials close to 1 keV photon energy for radiation applications. Radiation Physics and Chemistry. 2024;215:111375.
  19. Koshimizu M. Tissue-equivalent radio photo luminescence dosimetry materials based on production of luminescent molecules via radiation chemical reactions. Radiation Measurements. 2024;176:107222.
  20. Abdelmonem AM, Elshamndy SK, Ali MS. Studying of radiation attenuation and interaction parameters of some materials used in dental applications. Nuclear Instruments and Methods in Physics Research Section B. 2025;558:165575.
  21. Büyükyıldız M. Effective atomic numbers and electron densities for some lanthanide oxide compounds using direct method in the energy region of 1 keV–20 MeV. Bitlis Eren University Journal of Science and Technology. 2016;6(1):7–12.
  22. Rafiei MM, Parsaei S, Kaur P, Singh KJ, Büyükyıldız M, Kurudirek M. A Monte Carlo investigation of some important radiation parameters and tissue equivalency for photons below 1 keV in human tissues. Biomedical Physics & Engineering Express. 2022;8(2):025002.
  23. Oto B, Oto G, Madak Z, et al. The interaction of gamma radiation with drugs used in cholinergic medications. International Journal of Radiation Biology. 2020;96(2):236–244.
  24. Isikli Z, Oto B. Gamma or X-rays attenuation properties of some biochemical compounds. Radiation Effects and Defects in Solids. 2017;172(3–4):296–304.
  25. Mohammed SI, Taqi AH. Mass attenuation coefficient of electromagnetic radiation for human tissues. Journal of Radiation Research and Applied Sciences. 2025;18(1): 101255.
  26. Alshammari FM, Reda SM, Ghannam MM. Potential effects of gamma irradiation on the stability and therapeutic activity of anticancer drug doxorubicin. Journal of Radiation Research and Applied Sciences. 2017;10:103–109.
  27. Salehi D, Sardari D, Jozani MS. Investigation of some radiation shielding parameters in soft tissue. Journal of Radiation Research and Applied Sciences. 2015;8(3):439–445.
  28. Aygün B, Alaylar B, Turhan K, et al. Investigation of neutron and gamma radiation protective characteristics of synthesized quinoline derivatives. International Journal of Radiation Biology. 2020;96(11):1423–1434.
  29. Bayram S, Aygün B, Karadayı M, et al. Determination of toxicity and radioprotective properties of bacterial and fungal eumelanin pigments. International Journal of Radiation Biology. 2023;99(11):1785–1793.
  30. Akman F, Kaçal MR. Investigation of radiation attenuation parameters of some drugs used in chemotherapy in wide energy region. Journal of Radiology and Oncology. 2018;2:47–52.
  31. Kwatra D, Venugopal A, Anant S. Nanoparticles in radiation therapy: a summary of various approaches to enhance radiosensitization in cancer. Translational Cancer Research. 2013;2(4).
  32. Sayyed MI, Issa SA, Auda SH. Assessment of radio-protective properties of some anti-inflammatory drugs. Progress in Nuclear Energy. 2017;100:297–308.
  33. Belgin EE. Comparison of gamma spectrometric method and XCOM method in calculating mass attenuation coefficients of reinforced polymeric composite materials. Radiation Physics and Chemistry. 2022;193:109960.
  34. Gowda S, Krishnaveni S, Gowda R. Studies on effective atomic numbers and electron densities in amino acids and sugars in the energy range 30–1333 keV. Nuclear Instruments and Methods in Physics Research Section B. 2005;239(4):361–369.
  35. Gerward L, Guilbert N, Jensen KB, et al. WinXCom—a program for calculating X-ray attenuation coefficients. Radiation Physics and Chemistry. 2004;71(3–4):653–654.
  36. Gerward L, Guilbert N, Jensen KB, et al. X-ray absorption in matter: reengineering XCOM. Radiation Physics and Chemistry. 2001;60(1–2):23–24.
  37. Harima Y, Sakamoto Y, Tanaka SI, et al. Validity of the geometric-progression formula in approximating gamma-ray buildup factors. Nuclear Science and Engineering. 1986;94(1):24–3